Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive ...
Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...
Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...
Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the ...
150% increase recorded this year in internal hackathons at institute level, making this the largest edition so far ...
The results, reported at the San Antonio Breast Cancer Symposium (SABCS), added to the history of mixed messages from trials ...
SAN ANTONIO — A large trial has begun to make the case for active surveillance as an alternative to immediate surgery for low ...
Key takeawaysAnyone can view crypto transactions on public blockchains at any time.Viewing crypto transaction history reveals ...